A detailed history of Natixis Advisors, L.P. transactions in Icon PLC stock. As of the latest transaction made, Natixis Advisors, L.P. holds 166,584 shares of ICLR stock, worth $31.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
166,584
Previous 153,695 8.39%
Holding current value
$31.6 Million
Previous $48.2 Million 0.66%
% of portfolio
0.09%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$280.48 - $346.2 $3.62 Million - $4.46 Million
12,889 Added 8.39%
166,584 $47.9 Million
Q2 2024

Aug 01, 2024

SELL
$288.23 - $331.73 $26.8 Million - $30.9 Million
-93,029 Reduced 37.71%
153,695 $48.2 Million
Q1 2024

Apr 25, 2024

SELL
$247.84 - $340.0 $4.52 Million - $6.2 Million
-18,247 Reduced 6.89%
246,724 $82.9 Million
Q4 2023

Feb 06, 2024

SELL
$222.83 - $285.76 $1.3 Million - $1.66 Million
-5,820 Reduced 2.15%
264,971 $75 Million
Q3 2023

Nov 13, 2023

BUY
$236.44 - $265.62 $7.8 Million - $8.76 Million
32,987 Added 13.87%
270,791 $66.7 Million
Q2 2023

Aug 15, 2023

BUY
$183.12 - $250.2 $5.96 Million - $8.14 Million
32,551 Added 15.86%
237,804 $59.5 Million
Q1 2023

May 11, 2023

BUY
$193.59 - $245.33 $3.38 Million - $4.29 Million
17,477 Added 9.31%
205,253 $43.8 Million
Q4 2022

Jan 27, 2023

SELL
$173.9 - $224.8 $67,821 - $87,672
-390 Reduced 0.21%
187,776 $36.5 Million
Q3 2022

Nov 14, 2022

BUY
$183.25 - $247.5 $9.23 Million - $12.5 Million
50,384 Added 36.57%
188,166 $34.6 Million
Q2 2022

Aug 12, 2022

BUY
$197.3 - $261.32 $5.58 Million - $7.39 Million
28,295 Added 25.84%
137,782 $29.9 Million
Q1 2022

May 12, 2022

BUY
$216.09 - $296.03 $2.04 Million - $2.79 Million
9,432 Added 9.43%
109,487 $26.6 Million
Q4 2021

Feb 08, 2022

BUY
$258.11 - $309.7 $952,167 - $1.14 Million
3,689 Added 3.83%
100,055 $31 Million
Q3 2021

Nov 15, 2021

BUY
$208.53 - $283.04 $7.5 Million - $10.2 Million
35,983 Added 59.59%
96,366 $25.3 Million
Q2 2021

Aug 12, 2021

BUY
$194.07 - $232.2 $368,733 - $441,180
1,900 Added 3.25%
60,383 $12.5 Million
Q1 2021

May 05, 2021

SELL
$171.87 - $220.96 $123,746 - $159,091
-720 Reduced 1.22%
58,483 $11.5 Million
Q4 2020

Feb 12, 2021

SELL
$180.3 - $214.08 $4.48 Million - $5.32 Million
-24,850 Reduced 29.56%
59,203 $11.5 Million
Q3 2020

Nov 12, 2020

SELL
$166.91 - $196.1 $367,702 - $432,008
-2,203 Reduced 2.55%
84,053 $16.1 Million
Q2 2020

Aug 11, 2020

BUY
$129.79 - $170.94 $1.95 Million - $2.57 Million
15,014 Added 21.07%
86,256 $14.5 Million
Q1 2020

Apr 27, 2020

BUY
$115.95 - $177.22 $224,247 - $342,743
1,934 Added 2.79%
71,242 $9.69 Million
Q4 2019

Feb 10, 2020

BUY
$139.48 - $172.23 $867,007 - $1.07 Million
6,216 Added 9.85%
69,308 $11.9 Million
Q3 2019

Nov 12, 2019

SELL
$146.89 - $161.41 $855,781 - $940,374
-5,826 Reduced 8.45%
63,092 $9.3 Million
Q2 2019

Aug 12, 2019

SELL
$129.99 - $153.97 $263,749 - $312,405
-2,029 Reduced 2.86%
68,918 $10.6 Million
Q1 2019

May 15, 2019

SELL
$121.3 - $146.95 $845,582 - $1.02 Million
-6,971 Reduced 8.95%
70,947 $9.69 Million
Q4 2018

Feb 13, 2019

SELL
$119.37 - $153.29 $294,485 - $378,166
-2,467 Reduced 3.07%
77,918 $10.1 Million
Q3 2018

Nov 13, 2018

SELL
$131.3 - $153.75 $92,829 - $108,701
-707 Reduced 0.87%
80,385 $12.4 Million
Q2 2018

Aug 14, 2018

SELL
$111.38 - $137.03 $205,496 - $252,820
-1,845 Reduced 2.22%
81,092 $0
Q1 2018

May 10, 2018

BUY
$103.82 - $123.9 $3.25 Million - $3.87 Million
31,271 Added 60.53%
82,937 $9.8 Million
Q4 2017

Feb 14, 2018

SELL
$111.14 - $123.05 $4.09 Million - $4.53 Million
-36,841 Reduced 41.62%
51,666 $5.79 Million
Q3 2017

Nov 14, 2017

BUY
$101.4 - $116.62 $8.97 Million - $10.3 Million
88,507
88,507 $10.1 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $15.5B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.